Antibacterial effect of taurolidine (2%) on established dental plaque biofilm

Clinical Oral Investigations

Volumn 16, Issue 2, 2012, Pages 499-504

  Arweiler, Nicole Birgit ^a   Auschill, Thorsten Mathias ^a   Sculean, Anton ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Antibacterial agents; Biofilm vitality; Chlorhexidine; Plaque biofilm; Taurolidine

Indexed keywords

3',6' DIACETYLFLUORESCEIN; 3',6'-DIACETYLFLUORESCEIN; ANTIINFECTIVE AGENT; CHLORHEXIDINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ETHIDIUM; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; SODIUM CHLORIDE; TAURINE; TAUROLIDINE; THIADIAZINE DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BIOFILM; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; MALE; MICROBIAL VIABILITY; MICROBIOLOGY; MOLAR TOOTH; TOOTH PLAQUE;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BIOFILMS; CHLORHEXIDINE; DENTAL PLAQUE; ETHIDIUM; FEMALE; FLUORESCEINS; FLUORESCENT DYES; HUMANS; MALE; MICROBIAL VIABILITY; MICROSCOPY, FLUORESCENCE; MOLAR; SODIUM CHLORIDE; TAURINE; THIADIAZINES;

EID: 84858699054     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-011-0526-y     Document Type: Article

References (43)

1. Löe H, Theilade E, Jensen SB (1965) Gingivitis in man. J Periodontol 36: 177-187.
2. Theilade E, Wright WH, Jensen SB, Löe H (1966) Experimental gingivitis in man. II. A longitudinal clinical and bacteriological investigation. J Periodontal Res 1: 1-13.
3. Umeda M, Takeuchi Y, Noguchi K, Huang Y, Koshy G, Ishikawa I (2000) Effects of nonsurgical periodontal therapy on the microbiota. Periodontol 36: 98-120.
4. Brecx M (1997) Strategies and agents in supragingival chemical plaque control. Peridontology 2000 15: 100-108.
5. Jones CG (1997) Chlorhexidine: is it still the gold standard? Periodontol 2000(15): 55-62.
6. Addy M, Moran JM (1997) Evaluation of oral hygiene products: science is true; don't be misled by the facts. Periodontol 2000(15): 40-51.
7. Arweiler NB, Boehnke N, Sculean A, Hellwig E, Auschill TM (2006) Differences in efficacy of two commercial 0. 2% chlorhexidine mouthrinse solutions: a 4-day plaque re-growth study. J Clin Periodontol 33: 334-339.
8. Flötra L, Gjermo P, Rölla G, Waerhaug J (1972) A 4-month study on the effect of chlorhexidine mouthwashes on 50 soldiers. Scand J Dent Res 80: 10-17.
9. Addy M, Sharif N, Moran J (2005) A non-staining chlorhexidine mouthwash? Probably not: a study in vitro. Int J Dent Hyg 3: 59-63.
10. Gabler WL, Roberts D, Harold W (1987) The effect of chlorhexidine on blood cells. J Periodontal Res 22: 150-155.
11. Damour O, Hua SZ, Lasne F, Villain M, Rousselle P, Collombel C (1992) Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes. Burns 18: 479-485.
12. Tatnall FM, Leigh IM, Gibson JR (1990) Comparative study of antiseptic toxicity on basal keratinocytes, transformed human keratinocytes and fibroblasts. Skin Pharmacol 3: 157-163.
13. Babich H, Wurzburger BJ, Rubin YL, Sinensky MC, Blau L (1995) An in vitro study on the cytotoxicity of chlorhexidine digluconate to human gingival cells. Cell Biol Toxicol 11: 79-88.
14. Mariotti AJ, Rumpf DA (1990) Chlorhexidine-induced changes to human gingival fibroblast collagen and non-collagen protein production. J Periodontol 70: 1443-1448.
15. Wilken R, Botha SJ, Grobler A, Germishuys PJ (2001) In vitro cytotoxicity of chlorhexidine gluconate, benzydamine-HCl and povidone iodine mouthrinses on human gingival fibroblasts. SADJ 56: 455-460.
16. Müller G, Kramer A (2008) Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 61: 1281-1287.
17. Bhandari M, Adili A, Schemitsch EH (2001) The efficacy of low-pressure lavage with different irrigating solutions to remove adherent bacteria from bone. J Bone Joint Surg Am 83: 412-419.
18. Cabral CT, Fernandes MH (2007) In vitro comparison of chlorhexidine and povidone-iodine on the long-term proliferation and functional activity of human alveolar bone cells. Clin Oral Investig 11: 155-164.
19. Sanchez IR, Swaim SF, Nusbaum KE, Hale AS, Henderson RA, McGuire JA (1988) Effects of chlorhexidine diacetate and povidone-iodine on wound healing in dogs. Vet Surg 17: 291-295.
20. Bakaéen GS, Strahan JD (1980) Effects of a 1% chlorhexidine gel during the healing phase after inverse bevel mucogingival flap surgery. J Clin Periodontol 7: 20-25.
21. Langebaek J, Bay L (1976) The effect of chlorhexidine mouthrinse on healing after gingivectomy. Scand J Dent Res 84: 224-228.
22. Wade WG, Addy M (1989) In vitro activity of a chlorhexidine-containing mouthwash against subgingival bacteria. J Periodontol 60: 521-525.
23. Cimasoni F (1983) Crevicular fluid updated. Monogr Oral Sci 12(3-7): 1-152.
24. Moser G, Marti MC (1978) Stercoral peritonitis. A case treated successfully by intraperitoneal and intravenous administration of a new drug without antibiotic adjunction. J Chir 115: 175-176.
25. Browne MK (1981) The treatment of peritonitis by an antiseptic-taurolin. Pharmatherapeutica 2: 517-522.
26. Lob G, Hertlein H, Mittlmeier T (1994) Local chemotherapy of acute and chronic posttraumatic osteitis with Taurolin-Gel 4%. Orthop Traumatol 4: 123-124.
27. Tarhan OR, Barut I, Sezik M (2008) An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis. J Surg Res 144: 151-157.
28. Blenkharn (1987) The antimicrobial activity of Taurolin-a possible additive for parenteral nutrition solutions. Clin Nutr 6: 4.
29. Blenkharn JI (1988) Sustained anti-adherence activity of taurolidine (Taurolin) and noxythiolin (Noxyflex S) solutions. J Pharm Pharmacol 40: 509-511.
30. Caruso F, Darnowski JW, Opazo C, Goldberg A, Kishore N, Agoston ES, Rossi M (2010) Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall. PLoS ONE 5: e8927.
31. Chromik AM, Daigeler A, Bulut D, Flier A, May C, Harati K, Roschinsky J, Sülberg D, Ritter PR, Mittelkötter U, Hahn SA, Uhl W (2010) Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines. J Exp Clin Cancer Res 7: 21-29.
32. Neary PM, Hallihan P, Wang JH, Pfirrmann RW, Bouchier-Hayes DJ, Redmond HP (2010) The evolving role of taurolidine in cancer therapy. Ann Surg Oncol 17: 1135-1143.
33. Zimmermann M, Preac-Mursic V (1992) In vitro activity of taurolidine, chlorophenol-camphor-menthol and chlorhexidine against oral pathogenic microorganisms. Arzneim Forsch 42: 1157-1159.
34. Pfirrmann RW, Leslie GB (1979) The anti-endotoxin activity of Taurolin in experimental animals. J Appl Bacteriol 46: 97-102.
35. Wicki O, Pfirrmann RW (1979) Tauroline in peritonitis. Aktuelle Probl Chir Orthop 12: 42-48.
36. Mühlemann HR, Strub JR (1975) Inhibition of plaque growth with taurolin, vantocil and amine fluoride. Helv Odontol Acta 19: 57-60.
37. Reynolds S, Moran J, Addy M, Wade WG, Newcombe R (1991) Taurolin as an oral rinse. I. Antimicrobial effects in vitro and in vivo. Clin Prev Dent 13: 13-17.
38. Reynolds S, Moran J, Wade WG, Addy M, Newcombe R (1991) Taurolin as an oral rinse. II. Effects on in vitro and in vivo plaque regrowth. Clin Prev Dent 13: 18-22.
39. Netuschil L, Reich E, Brecx M (1989) Direct measurement of the bactericidal effect of chlorhexidine on human dental plaque. J Clin Periodontol 16: 484-488.
40. Millward TA, Wilson M (1989) The effect of chlorhexidine on Streptococcus sanguis biofilms. Microbios 58: 155-164.
41. Guggenheim B, Giertsen E, Schüpbach P, Shapiro S (2001) Validation of an in vitro biofilm model on supragingival plaque. J Dent Res 80: 363-370.
42. Sculean A, Auschill TM, Donos N, Brecx M, Arweiler NB (2001) Effect of an enamel matrix protein derivative (Emdogain) on ex vivo dental plaque vitality. J Clin Periodontol 28: 1074-1078.
43. Arweiler NB, Auschill TM, Donos N, Sculean A (2002) Antibacterial effect of an enamel matrix protein derivative on in vivo dental biofilm vitality. Clin Oral Investig 6: 205-209.